We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Daniel Hayes

Daniel F. Hayes MD

Stuart A. Padnos Professor of Breast Cancer Research and Professor of Internal Medicine, University of Michigan Medical School

After receiving his undergraduate and graduate degrees from Indiana University in Bloomington, Indiana, Dr. Hayes attended medical school at Indiana University School of Medicine in Bloomington. He underwent residency in internal medicine at University of Texas Southwestern Medical School in Dallas, and then went on to complete a fellowship in medical oncology at Dana-Farber Cancer Institute in Boston, Massachusetts.

 

Dr. Hayes is the Stuart A. Padnos Professor of Breast Cancer Research and a tenured Professor in Internal Medicine at the University of Michigan Medical School. He is an internationally recognized expert in translational breast cancer research. He has been involved in investigations of several novel agents, and, more importantly, is a leader in biomarker development, evaluation, and clinical utility, including circulating MUC1 and HER2, circulating tumor cells, several tissue-based biomarkers (MUC1, neo-vascularization, HER2, ALDH1), and germline factors associated with drug metabolism and activity. He is the Co-Director of the Breast Oncology Program (BOP) at the University of Michigan Comprehensive Cancer Center. He directs both the clinical and translational research activities within the BOP, as well as research activities in his own, independently funded laboratory. Dr. Hayes serves as Chair or Co-Chair of the Breast Cancer Translational Medicine Committee of the Southwest Oncology Group, the Correlative Science Committee of the North American Breast Cancer Group, the TransOx Correlative Science Committee of the Early Breast Cancer Trialists’ Collaborative Group, the Consortium on Breast Cancer Pharmacogenomics, and the American Society of Clinical Oncology Tumor Marker Guidelines Committee. He has authored over 250 peer-reviewed papers and other educationally relevant materials. He served as the Chair of the Scientific Program Committee for the 2010 ASCO Annual Meeting, and, in 2007, he was the inaugural recipient of the ASCO Gianni Bonadonna Breast Cancer Award for translational research and mentoring.